Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Vernakalant> ?p ?o }
- Vernakalant abstract "Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009. In September 2012, Merck terminated its agreements with Cardiome and has consequently returned all rights of the drug back to Cardiome.On 11 December 2007, the Cardiovascular and Renal Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted to recommend the approval of vernakalant, but in August 2008 the FDA judged that additional information was necessary for approval. The drug (under brand name Brinavess) was approved in Europe on 1 September 2010.An oral formulation underwent Phase II clinical trials between 2005 and 2008.".
- Vernakalant atcPrefix "C01".
- Vernakalant atcSuffix "BG11".
- Vernakalant casNumber "794466-70-9".
- Vernakalant casSupplemental "(HCl)".
- Vernakalant fdaUniiCode "9G468C8B13".
- Vernakalant iupacName "(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)".
- Vernakalant iupacName "ethoxy]cyclohexyl}pyrrolidin-3-ol".
- Vernakalant pubchem "9930049".
- Vernakalant thumbnail Vernakalant.svg?width=300.
- Vernakalant wikiPageID "16313649".
- Vernakalant wikiPageLength "5896".
- Vernakalant wikiPageOutDegree "22".
- Vernakalant wikiPageRevisionID "707497720".
- Vernakalant wikiPageWikiLink Antiarrhythmic_agent.
- Vernakalant wikiPageWikiLink Atrial_fibrillation.
- Vernakalant wikiPageWikiLink Atrium_(heart).
- Vernakalant wikiPageWikiLink Cardiac_transient_outward_potassium_current.
- Vernakalant wikiPageWikiLink Cardiome_Pharma.
- Vernakalant wikiPageWikiLink Category:Alcohols.
- Vernakalant wikiPageWikiLink Category:Antiarrhythmic_agents.
- Vernakalant wikiPageWikiLink Category:Phenol_ethers.
- Vernakalant wikiPageWikiLink Category:Pyrrolidines.
- Vernakalant wikiPageWikiLink Clinical_trial.
- Vernakalant wikiPageWikiLink Food_and_Drug_Administration.
- Vernakalant wikiPageWikiLink HERG.
- Vernakalant wikiPageWikiLink Heart_rate.
- Vernakalant wikiPageWikiLink Hydrochloride.
- Vernakalant wikiPageWikiLink International_nonproprietary_name.
- Vernakalant wikiPageWikiLink Intravenous_therapy.
- Vernakalant wikiPageWikiLink Merck_&_Co..
- Vernakalant wikiPageWikiLink Potassium_channel.
- Vernakalant wikiPageWikiLink QT_interval.
- Vernakalant wikiPageWikiLink Sodium_channel.
- Vernakalant wikiPageWikiLink Ventricular_tachycardia.
- Vernakalant wikiPageWikiLinkText "Vernakalant".
- Vernakalant wikiPageWikiLinkText "vernakalant".
- Vernakalant atcPrefix "1.0".
- Vernakalant atcSuffix "BG11".
- Vernakalant c "20".
- Vernakalant casNumber "794466".
- Vernakalant chemspiderid "8105680".
- Vernakalant h "31".
- Vernakalant inchi "1".
- Vernakalant inchikey "VBHQKCBVWWUUKN-KZNAEPCWBT".
- Vernakalant iupacName "-1".
- Vernakalant iupacName "ethoxy]cyclohexyl}pyrrolidin-3-ol".
- Vernakalant legalStatus "Rx-only".
- Vernakalant licenceEu "Brinavess".
- Vernakalant molecularWeight "349.464".
- Vernakalant n "1".
- Vernakalant o "4".
- Vernakalant pubchem "9930049".
- Vernakalant routesOfAdministration "Intravenous, oral".
- Vernakalant smiles "OC".
- Vernakalant stdinchi "1".
- Vernakalant stdinchikey "VBHQKCBVWWUUKN-KZNAEPCWSA-N".
- Vernakalant unii "9".
- Vernakalant verifiedfields "changed".
- Vernakalant verifiedrevid "446573380".
- Vernakalant watchedfields "changed".
- Vernakalant wikiPageUsesTemplate Template:Antiarrhythmic_agents.
- Vernakalant wikiPageUsesTemplate Template:CAS.
- Vernakalant wikiPageUsesTemplate Template:Cascite.
- Vernakalant wikiPageUsesTemplate Template:Chemspidercite.
- Vernakalant wikiPageUsesTemplate Template:Drugbankcite.
- Vernakalant wikiPageUsesTemplate Template:Drugbox.
- Vernakalant wikiPageUsesTemplate Template:Fdacite.
- Vernakalant wikiPageUsesTemplate Template:Reflist.
- Vernakalant wikiPageUsesTemplate Template:Stdinchicite.
- Vernakalant wikiPageUsesTemplate Template:Use_dmy_dates.
- Vernakalant subject Category:Alcohols.
- Vernakalant subject Category:Antiarrhythmic_agents.
- Vernakalant subject Category:Phenol_ethers.
- Vernakalant subject Category:Pyrrolidines.
- Vernakalant hypernym Drug.
- Vernakalant type Agent.
- Vernakalant type ChemicalSubstance.
- Vernakalant type Drug.
- Vernakalant type Agent.
- Vernakalant type Alcohol.
- Vernakalant type Chemical.
- Vernakalant type Drug.
- Vernakalant type Ether.
- Vernakalant type Heterocycle.
- Vernakalant type Redirect.
- Vernakalant type ChemicalObject.
- Vernakalant type Thing.
- Vernakalant type Q8386.
- Vernakalant comment "Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009.".
- Vernakalant label "Vernakalant".
- Vernakalant sameAs Q665725.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs m.03wgqxr.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs Q665725.
- Vernakalant wasDerivedFrom Vernakalant?oldid=707497720.